scholarly journals P4‐28: Case series: High flow nasal cannula in carbon monoxide intoxication

Respirology ◽  
2021 ◽  
Vol 26 (S3) ◽  
pp. 153-153
Keyword(s):  
Carbon Monoxide ◽  
Case Series ◽  
High Flow ◽  
Nasal Cannula ◽  
High Flow Nasal Cannula ◽  
Carbon Monoxide Intoxication

Determination of carboxyhemoglobin half-life in patients with carbon monoxide toxicity treated with high flow nasal cannula oxygen therapy

2019 ◽  
Vol 57 (7) ◽  
pp. 617-623 ◽  
Author(s):  
Ibrahim Ulas Ozturan ◽  
Elif Yaka ◽  
Selim Suner ◽  
Asim Enes Ozbek ◽  
Cansu Alyesil ◽  
...  
Keyword(s):  
Carbon Monoxide ◽  
Half Life ◽  
Oxygen Therapy ◽  
High Flow ◽  
Nasal Cannula ◽  
High Flow Nasal Cannula

scholarly journals Carbon Monoxide Poisoning Effectively Treated with High-flow Nasal Cannula

2019 ◽  
Vol 4 (1) ◽  
pp. 42-45
Author(s):  
Patrick Lee ◽  
Steven Salhanick
Keyword(s):  
Carbon Monoxide ◽  
Carbon Monoxide Poisoning ◽  
High Flow ◽  
Nasal Cannula ◽  
The Novel ◽  
Co Poisoning ◽  
High Flow Nasal Cannula ◽  
Disease States ◽  
Cohb Level ◽  
Potential Option

Carbon monoxide (CO) poisoning is typically treated by administration of oxygen via non-rebreather mask (NRB). High-flow nasal cannula (HFNC) is an alternative to NRB in a variety of disease states. We report a case of the novel use of HFNC in the treatment of acute CO poisoning. A 29-year-old man presented with a carboxyhemoglobin (COHb) level of 29.8%. He was treated with HFNC, and COHb levels declined to 5.4% in 230 minutes. Given several theoretical advantages of HFNC relative to NRB, HFNC is a potential option for use in the treatment of CO poisoning.

scholarly journals Use of high-flow nasal cannula in obese patients receiving colonoscopy under intravenous propofol sedation: A case series

2018 ◽  
Vol 23 ◽  
pp. 118-121 ◽  
Author(s):  
Chi Chan Lee ◽  
Osman Perez ◽  
Faryal I. Farooqi ◽  
Trupti Akella ◽  
Sameer Shaharyar ◽  
...  
Keyword(s):  
Case Series ◽  
High Flow ◽  
Nasal Cannula ◽  
Obese Patients ◽  
High Flow Nasal Cannula ◽  
Propofol Sedation

A case series of paediatric high flow nasal cannula therapy

2013 ◽  
Vol 26 (4) ◽  
pp. 189-192 ◽  
Author(s):  
Sara Mayfield ◽  
Jacqueline Jauncey-Cooke ◽  
Fiona Bogossian
Keyword(s):  
Case Series ◽  
High Flow ◽  
Nasal Cannula ◽  
High Flow Nasal Cannula

Corrigendum to ‘‘High-flow nasal cannula oxygen therapy for acute exacerbation of interstitial pneumonia: A case series’’

2016 ◽  
Vol 54 (4) ◽  
pp. 296
Author(s):  
Yukihiro Horio ◽  
Takahisa Takihara ◽  
Kyoko Niimi ◽  
Masamichi Komatsu ◽  
Masako Sato ◽  
...  
Keyword(s):  
Acute Exacerbation ◽  
Interstitial Pneumonia ◽  
Oxygen Therapy ◽  
Case Series ◽  
High Flow ◽  
Nasal Cannula ◽  
High Flow Nasal Cannula

scholarly journals Spontaneous Pneumothorax in COVID-19 Patients Treated with High-Flow Nasal Cannula outside the ICU: A Case Series

2021 ◽  
Vol 18 (4) ◽  
pp. 2191
Author(s):  
Magdalena Nalewajska ◽  
Wiktoria Feret ◽  
Łukasz Wojczyński ◽  
Wojciech Witkiewicz ◽  
Magda Wiśniewska ◽  
...  
Keyword(s):  
Spontaneous Pneumothorax ◽  
Previous History ◽  
Case Series ◽  
High Flow ◽  
Nasal Cannula ◽  
High Flow Nasal Cannula ◽  
Positive Effects ◽  
Non Invasive ◽  
Global Pandemic ◽  
History Of

The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has become a global pandemic and a burden to global health at the turn of 2019 and 2020. No targeted treatment for COVID-19 infection has been identified so far, thus supportive treatment, invasive and non-invasive oxygen support, and corticosteroids remain a common therapy. High-flow nasal cannula (HFNC), a non-invasive oxygen support method, has become a prominent treatment option for respiratory failure during the SARS-CoV-2 pandemic. HFNC reduces the anatomic dead space and increases positive end-expiratory pressure (PEEP), allowing higher concentrations and higher flow of oxygen. Some studies suggest positive effects of HFNC on mortality and avoidance of intubation. Spontaneous pneumothorax has been observed in patients suffering from SARS-CoV-2 pneumonia. Although the viral infection itself contributes to its development, higher PEEP generated by both HFNC and mechanical ventilation is another risk factor for increased alveoli damage and air-leak. Herein, we present three cases of patients with no previous history of lung diseases who were diagnosed with COVID-19 viral pneumonia. All of them were supported with HFNC, and all of them presented spontaneous pneumothorax.

High-flow nasal cannula oxygen therapy for acute exacerbation of interstitial pneumonia: A case series

2016 ◽  
Vol 54 (2) ◽  
pp. 125-129 ◽  
Author(s):  
Yukihiro Horio ◽  
Takahisa Takihara ◽  
Kyoko Niimi ◽  
Masamichi Komatsu ◽  
Masako Sato ◽  
...  
Keyword(s):  
Acute Exacerbation ◽  
Interstitial Pneumonia ◽  
Oxygen Therapy ◽  
Case Series ◽  
High Flow ◽  
Nasal Cannula ◽  
High Flow Nasal Cannula
Sign in / Sign up

Export Citation Format

Share Document